Navigation Links
Anxiety linked to sleep disturbances
Date:11/1/2007

WESTCHESTER, Ill. People who suffer from anxiety from stressful life situations may be more likely to experience sleep disturbances for at least the first six months after the event, according to a study published in the November 1 issue of the journal SLEEP.

The study, authored by Jussi Vahtera, MD, of the Finnish Institute of Occupational Health in Helsinki, Finland, focused on a population sample of 16,627 men and women with undisturbed sleep and 2,572 with disturbed sleep, all of whom participated in a five-year longitudinal observational cohort study.

A measurement of each persons liability to anxiety, as determined by a general feeling of stressfulness and symptoms of hyperactivity, was assessed at the onset. The occurrence of post-onset life events (i.e., death or illness in the family, divorce, financial difficulty and violence) and sleep disturbances was measured at follow-up five years later.

According to the results, both liability to anxiety and exposure to negative life events were strongly associated with sleep disturbances. Among the men liable to anxiety, the odds of sleep disturbances were 3.11 times higher for those who had experienced a severe life event within six months than for the others. The men not liable to anxiety had odds of only 1.13 for sleep disturbances. For the men and women liable to anxiety, the odds ratio for sleep disturbance zero to six months after divorce was 2.05, with the corresponding ratio being 1.47 for those not liable to anxiety.

This five-year follow-up showed that exposure to severe stressful events can trigger sleep disturbances in people with undisturbed sleep before the event. Those liable to anxiety before the event seemed to be at a higher risk of post-event sleep disturbances compared with those not liable to anxiety. The strength of this study is a study design that allowed the timing of pre-event predisposing traits and the occurrence of specific stressful events
'/>"/>

Contact: Jim Arcuri
jarcuri@aasmnet.org
708-492-0930
American Academy of Sleep Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Bruxism linked to anxiety disorder
2. Nausea Linked To Anxiety And Depression
3. Anxiety likely to affect the foetus
4. Social anxiety has hope from a new drug
5. New approach to anti-anxiety drugs
6. Anxiety and Peptic ulcers may be linked
7. Anxiety following heart attacks not adequately managed
8. Valium hits 40 years old, anxiety-free
9. Structure of the brain to increase risk for anxiety disorders
10. Kidney Donors Health Can Cause Anxiety Among Kidney Recipients
11. Herbal Remedies For Insomnia And Anxiety May Be Ineffective

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... 3D animation detailing plastic s... Elements website. Surgical candidates can view pr...ctly from the page. , (PR...ine compression garments retailer, has always been...ery patients after their procedures, providing lip...
(Date:12/2/2009)... myEMRchoice.com Enables Personal... Fort Washington, PA (PRWEB) Dec...o give consumers is to read their own medical reco...), keeping control of personal medical records is ...on, PA based healthcare technology company has add...
(Date:12/2/2009)... Award-winning author James A. Fe...th book, Short White Coat: Lessons from Patients o...ough the third year of medical school--the gruelin...ELPHIA, PA (PRWEB) December 2, 2009 -- Most peopl...selves dressed in a tiny hospital gown or staring ...
(Date:12/2/2009)... Leading medical device software ... has received ISO 13485 certification. A relativel...ng firms have actually achieved ISO 13485 certific...ertification and adhere to other ISO standards as ...evice software engineering consulting firm to achi...
(Date:12/2/2009)..., SAN DIEGO, Dec. 2 G...t at the 21st Annual Piper Jaffray Health Care Con...ntation is scheduled to be webcast live and may be...of Gen-Probe,s website at www.gen-probe.com . The...he event. ,, About Gen-Probe ,, Gen-Probe...
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:Personal Health Records On-Demand, In Your Pocket 2Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Medical Device Software Engineering Consulting firm Full Spectrum Software Earns ISO 13485 Certification 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2
...ments for what doctors say is a life-threatening m...hDay News) -- Sen. Edward M. Kennedy enjoyed "a re...of Duke University Medical Center on Tuesday, one ...y was "recuperating well from yesterday,s procedur...
... to be more clear in explaining realities , ...ons not easily understood, many patients with the ...onger than their doctors tell them they will, new ...lity to pump blood -- that the condition would sho...
...nown origin, rheumatoid arthritis (RA) affects abo... destruction, RA often leads to disability and dim...arly death from cancer. Various studies have link...modifying antirheumatic drug (DMARD) commonly pres...
... Underwriters- -Offers Specialized Coverage fo..., June 3 The Hanover,Insurance Group, Inc. (NYSE:...ualty company, today announced it has extended the...ia. The program,offers specialized protection to m...
...ployee,Benefit Research Institute (EBRI) today pub...of the amount of money individuals and couples wil...tirement. The new estimates,attempt to provide mor...f medical care coverage available when they,reach ...
... pancreatic and spinal cancer, SHERWOOD, Ore., Ju...a quiet life at Avamere at,Sherwood in Oregon. The...ngs and frequent visits from his daughter Yolanda ...g cruises for,celebrities. In 1977, he finished Ey...
Other Medicine News:Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 2Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 3Health News:Sen. Kennedy Up and Walking After Brain Tumor Surgery 4Health News:Heart Failure Patients Overestimate Their Life Expectancy 2Health News:Heart Failure Patients Overestimate Their Life Expectancy 3Health News:Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate 2Health News:Increased incidence of melanoma found in rheumatoid arthritis patients treated with methotrexate 3Health News:The Hanover Extends Schools Program, Making the Grade in GA, KS, MD, and VA 2Health News:The Hanover Extends Schools Program, Making the Grade in GA, KS, MD, and VA 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 2Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 3Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 4Health News:New Research From EBRI: Estimates Show More Precise Retiree Health Savings Needs 5Health News:Sherwood, Oregon Sailor, 78, Goes on Final Voyage 2
(Date:12/1/2009)...., Dec. 1 CeloNova BioSciences, In... medical devices and of specialty implants, today ..., founder and medical director of Baptist Cardiac ...iscuss the CATANIA(TM) Stent System with NanoThin ...lar Interventions Conference to be held at the Hot...
(Date:12/1/2009)... and TOKYO, Dec. 1 Galenea Corp. a... the further extension of their research and devel...tension increases the collaboration term to seven ...proximately $90 million. The companies have been ...of discovering and developing first-in-class thera...
(Date:12/1/2009)...., Dec. 1 SCOLR Pharma, ... 20, 2009 it licensed to Chrono Nutraceuticals LLC...l four extended release dietary supplements using ...rm. In addition, SCOLR granted Chrono rights to m...ited States on a nonexclusive basis. Chrono paid ...
Breaking Medicine Technology:Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 2Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration 3SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3American Nurses Association Joins the National Healthcare Career Network 54285 1American Nurses Association Joins the National Healthcare Career Network 54285 2American Nurses Association Joins the National Healthcare Career Network 54285 3Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 1Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 2Scientist Verifies That The Ancient Practice Of Girding The Loins Increases Health 54281 3The tourist trap 9540 1
...ial New Front-Line Treatment ...Genzyme Corp.,(Nasdaq: GENZ ) reported preliminar...2 study examining the safety and effectiveness of ...ously untreated, older adult,patients with acute m...fit,from conventional "7+3" anthracycline plus cyt...
...CALS, INC. (Nasdaq: VION ) today announced that i... lead anticancer agent Cloretazine(R),(VNP40101M) ...yelogenous,leukemia (AML) had been presented at th...linical Oncology (ASCO(R)) in Chicago, Illinois., ...atients. The median,age of these patients was 73 y...
Other Medicine Technology:Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 2Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 3Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 4Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 5Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 6Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 7Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients 8Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 2Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 3Vion Pharmaceuticals Announces Presentation of Interim Data from Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Acute Myelogenous Leukemia at the ASCO(R) Annual Meeting 4
...t-Cath, Maximum, Maximum Xtra™, and Maximum ...of standard and specialty hemostasis introducers i...mostasis introducers for use in interventional car... angiography, angioplasty, stenting, atherectomy, ...
Lumenis 950 Slit Lamp
Selecta Duo Photocoagulator Combination Laser
Apeel™ CS Catheter Delivery System
Medicine Products: